Albert David

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE155C01010
NSEID: ALBERTDAVD
BSEID: 524075

INR

796.45

26.1 (3.39%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 4.21 k

{
  "main_header": {
    "sid": 876497,
    "name": "Albert David",
    "stock_name": "Albert David",
    "full_name": "Albert David Ltd",
    "name_url": "stocks-analysis/albert-david",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "796.45",
    "chg": 26.1,
    "chgp": "3.39%",
    "dir": 1,
    "prev_price": "770.35",
    "mcapval": "454.55 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524075,
    "symbol": "ALBERTDAVD",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE155C01010",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "23:56 PM",
    "bse_nse_vol": "4.21 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/albert-david-876497-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Albert David Faces Significant Challenges Amidst Broader Market Recovery",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/albert-david-ltd-hits-52-week-low-amid-continued-stock-decline-and-poor-financial-results-1399996",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/AlbertDavid_priceRelatedfactors_680486.png",
        "date": "2025-03-17 09:53:32",
        "description": "Albert David, a microcap pharmaceutical company, has faced notable volatility, reaching a new 52-week low. The stock has declined significantly over the past five days and year, underperforming its sector. Financial metrics indicate a sharp drop in operating profit and net sales, raising concerns about its performance amid market recovery."
      },
      {
        "title": "Albert David Faces Significant Volatility Amidst Declining Financial Performance and Bearish Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/albert-david-ltd-hits-52-week-low-amid-continued-decline-in-stock-performance-1400055",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/AlbertDavid_priceRelatedfactors_680482.png",
        "date": "2025-03-17 09:53:29",
        "description": "Albert David, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low amid significant volatility and a five-day losing streak. The stock has declined 27.23% over the past year, with concerning financial results, including a net profit drop and low quarterly sales, reflecting a challenging market environment."
      },
      {
        "title": "Albert David Faces Significant Challenges Amidst Declining Financial Performance and Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/albert-david-stock-hits-52-week-low-amid-significant-decline-in-performance-1400086",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/AlbertDavid_priceRelatedfactors_680480.png",
        "date": "2025-03-17 09:53:26",
        "description": "Albert David, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low amid significant volatility. The stock has underperformed, declining over 10% in the past five days and 27.23% over the year, with concerning financial results including a net loss and declining sales."
      },
      {
        "title": "Albert David Faces Significant Challenges Amidst Declining Financial Performance and Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/albert-david-ltd-hits-52-week-low-amid-ongoing-decline-and-weak-financial-results-1400104",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/AlbertDavid_priceRelatedfactors_680479.png",
        "date": "2025-03-17 09:53:22",
        "description": "Albert David, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low amid significant volatility. The stock has underperformed its sector and declined over the past year. Recent financial results show a substantial net loss and decreasing sales, raising concerns about its outlook."
      },
      {
        "title": "Albert David Faces Continued Challenges Amid Significant Stock Volatility and Declining Profitability",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/albert-david-stock-hits-52-week-low-amid-continued-decline-and-poor-financial-results-1348772",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/AlbertDavid_priceRelatedfactors_677953.png",
        "date": "2025-03-13 15:39:21",
        "description": "Albert David, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low, continuing a downward trend with a significant decline over the past year. Key financial metrics indicate a troubling decrease in operating profit and disappointing quarterly results, reflecting ongoing market challenges."
      },
      {
        "title": "Albert David Hits 52-Week Low Amid Declining Profit and Sales Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/albert-david-ltd-hits-52-week-low-amid-declining-performance-and-bearish-trends-1180143",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/AlbertDavid_priceRelatedfactors_565384.png",
        "date": "2025-03-04 10:25:20",
        "description": "Albert David, a microcap in the Pharmaceuticals & Drugs sector, reached a new 52-week low today after a three-day decline, despite outperforming its sector. The company reported a significant drop in profit after tax and net sales, raising concerns about its financial health and market performance over the past year."
      },
      {
        "title": "Albert David Reaches 52-Week Low Amidst Ongoing Market Challenges in Pharmaceuticals Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/albert-david-ltd-hits-52-week-low-of-rs-811-7-amid-40-75-annual-decline-1040079",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/AlbertDavid_priceRelatedfactors_451062.png",
        "date": "2025-02-17 09:40:42",
        "description": "Albert David, a microcap in the Pharmaceuticals & Drugs sector, reached a new 52-week low today, reflecting a significant decline over the past year. Despite a slight recovery after six days of losses, the stock remains below key moving averages, indicating ongoing challenges in the market."
      },
      {
        "title": "Albert David Faces Persistent Bearish Trend Amid Broader Market Volatility in October 2023",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/albert-david-stock-hits-52-week-low-at-rs-900-amid-25-31-decline-1008684",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/AlbertDavid_priceRelatedfactors_440045.png",
        "date": "2025-02-14 09:36:45",
        "description": "Albert David, a microcap in the Pharmaceuticals & Drugs sector, has reached a new 52-week low, continuing a downward trend with a 25.31% decline over the past six trading days. Its one-year performance shows a 34.47% drop, contrasting with the Sensex's gain of 6.03%."
      },
      {
        "title": "Albert David Faces Significant Volatility Amidst Sustained Downward Trend in Pharmaceuticals Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/albert-david-ltd-hits-52-week-low-of-rs-970-amid-significant-decline-997176",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/AlbertDavid_priceRelatedfactors_426057.png",
        "date": "2025-02-13 09:38:00",
        "description": "Albert David, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low of Rs. 970 amid significant volatility. The stock has declined 19.26% over the past five days and is trading below all major moving averages, reflecting ongoing challenges in its market performance."
      }
    ],
    "total": 47,
    "sid": "876497",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/albert-david-876497"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "04-Apr-2025",
      "details": "Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018 for the period 01-01-2025 to 31-03-2025",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "21-Mar-2025",
      "details": "Closure of Trading Window from 1st April 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
      "datetime": "10-Mar-2025",
      "details": "Resignation of Mr. Shirish Gundopant Belapure Independent Director w.e.f 10.03.2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Albert David Ltd has declared <strong>115%</strong> dividend, ex-date: 02 Aug 24",
          "dt": "2024-08-02",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Albert David Faces Significant Challenges Amidst Broader Market Recovery

2025-03-17 09:53:32

Albert David, a microcap pharmaceutical company, has faced notable volatility, reaching a new 52-week low. The stock has declined significantly over the past five days and year, underperforming its sector. Financial metrics indicate a sharp drop in operating profit and net sales, raising concerns about its performance amid market recovery.

Albert David Faces Significant Volatility Amidst Declining Financial Performance and Bearish Indicators

2025-03-17 09:53:29

Albert David, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low amid significant volatility and a five-day losing streak. The stock has declined 27.23% over the past year, with concerning financial results, including a net profit drop and low quarterly sales, reflecting a challenging market environment.

Albert David Faces Significant Challenges Amidst Declining Financial Performance and Market Volatility

2025-03-17 09:53:26

Albert David, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low amid significant volatility. The stock has underperformed, declining over 10% in the past five days and 27.23% over the year, with concerning financial results including a net loss and declining sales.

Albert David Faces Significant Challenges Amidst Declining Financial Performance and Market Volatility

2025-03-17 09:53:22

Albert David, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low amid significant volatility. The stock has underperformed its sector and declined over the past year. Recent financial results show a substantial net loss and decreasing sales, raising concerns about its outlook.

Albert David Faces Continued Challenges Amid Significant Stock Volatility and Declining Profitability

2025-03-13 15:39:21

Albert David, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low, continuing a downward trend with a significant decline over the past year. Key financial metrics indicate a troubling decrease in operating profit and disappointing quarterly results, reflecting ongoing market challenges.

Albert David Hits 52-Week Low Amid Declining Profit and Sales Concerns

2025-03-04 10:25:20

Albert David, a microcap in the Pharmaceuticals & Drugs sector, reached a new 52-week low today after a three-day decline, despite outperforming its sector. The company reported a significant drop in profit after tax and net sales, raising concerns about its financial health and market performance over the past year.

Albert David Reaches 52-Week Low Amidst Ongoing Market Challenges in Pharmaceuticals Sector

2025-02-17 09:40:42

Albert David, a microcap in the Pharmaceuticals & Drugs sector, reached a new 52-week low today, reflecting a significant decline over the past year. Despite a slight recovery after six days of losses, the stock remains below key moving averages, indicating ongoing challenges in the market.

Albert David Faces Persistent Bearish Trend Amid Broader Market Volatility in October 2023

2025-02-14 09:36:45

Albert David, a microcap in the Pharmaceuticals & Drugs sector, has reached a new 52-week low, continuing a downward trend with a 25.31% decline over the past six trading days. Its one-year performance shows a 34.47% drop, contrasting with the Sensex's gain of 6.03%.

Albert David Faces Significant Volatility Amidst Sustained Downward Trend in Pharmaceuticals Sector

2025-02-13 09:38:00

Albert David, a microcap in the Pharmaceuticals & Drugs sector, has hit a new 52-week low of Rs. 970 amid significant volatility. The stock has declined 19.26% over the past five days and is trading below all major moving averages, reflecting ongoing challenges in its market performance.